Summit Therapeutics Inc vs Tapestry, Inc. — how do they compare? Summit Therapeutics Inc trades at $14.57 (market cap $10.48B), while Tapestry, Inc. trades at $140.62 (market cap $28.51B). The key difference: Tapestry, Inc. is far larger — about 2.7× Summit Therapeutics Inc's market cap, and Tapestry, Inc. pays a 1.13% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| SMMT | TPR | |
|---|---|---|
Market Cap | $10.48B | $28.51B |
Sector | Health | Consumer Cyclical |
52-Week High | $29.32 | $160.49 |
52-Week Low | $13.05 | $95.69 |
Enterprise Value | $9.90B | $31.37B |
Dividend Yield | — | 1.13% |
Trailing returns across standard periods
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →Coach, Kate Spade, and Stuart Weitzman are the fashion and accessory brands that comprise Tapestry. The firm's products are sold through about 1,400 company-operated stores, wholesale channels, and e-commerce in North America (67% of fiscal 2022 sales), Europe, Asia (28% of fiscal 2022 sales), and elsewhere. Coach (74% of fiscal 2022 sales) is best known for affordable luxury leather products. Kate Spade (22% of fiscal 2022 sales) is known for colorful patterns and graphics. Women's handbags and accessories produced 69% of Tapestry's sales in fiscal 2022. Stuart Weitzman, Tapestry's smallest brand, generates nearly all its revenue from women's footwear.
Read more on TPR →